tiprankstipranks
Trending News
More News >
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market
Advertisement

Shin Nippon Biomedical Laboratories, Ltd. (2395) Revenue

Compare
2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Revenue

Shin Nippon Biomedical Laboratories, Ltd. had a revenue of 9.73B in the quarter ending Dec 31, 2024, with 39.78%. This bring the company's revenue in the last twelve months to 30.70B, Decreased 13.39%. In the fiscal year ending Mar 31, 2025, Shin Nippon Biomedical Laboratories, Ltd. had annual revenue of 32.41B with 22.55% growth.
Revenue (ttm)
30.70B
Revenue Growth
22.55%
P/S Ratio
1.81
Revenue/Employee
¥22,246,951
Employees
1,457
Market Cap
¥58.70B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
32.41B5.96B+22.55%
Mar 31, 2024
26.45B1.36B+5.42%
Mar 31, 2023
25.09B7.34B+41.37%
Mar 31, 2022
17.75B2.64B+17.46%
Mar 31, 2021
15.11B549.46M+3.77%
Mar 31, 2020
14.56B-1.10B-7.01%
Mar 31, 2019
15.66B-941.87M-5.67%
Mar 31, 2018
16.60B-643.95M-3.73%
Mar 31, 2017
17.24B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis